SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016840
Filing Date
2022-08-11
Accepted
2022-08-11 16:03:20
Documents
70
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q sbtx-20220630.htm   iXBRL 10-Q 2106690
2 EX-2.1 sbtx-ex2_1.htm EX-2.1 1267541
3 EX-10.2 sbtx-ex10_2.htm EX-10.2 43874
4 EX-10.3 sbtx-ex10_3.htm EX-10.3 32095
5 EX-31.1 sbtx-ex31_1.htm EX-31.1 20697
6 EX-31.2 sbtx-ex31_2.htm EX-31.2 20696
7 EX-32.1 sbtx-ex32_1.htm EX-32.1 26156
8 GRAPHIC img44284211_0.jpg GRAPHIC 5956
  Complete submission text file 0000950170-22-016840.txt   8317908

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sbtx-20220630_cal.xml EX-101.CAL 32406
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sbtx-20220630.xsd EX-101.SCH 43102
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sbtx-20220630_lab.xml EX-101.LAB 345756
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sbtx-20220630_def.xml EX-101.DEF 149696
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sbtx-20220630_pre.xml EX-101.PRE 269406
64 EXTRACTED XBRL INSTANCE DOCUMENT sbtx-20220630_htm.xml XML 1147648
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39756 | Film No.: 221155589
SIC: 2834 Pharmaceutical Preparations